Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02200276 · ClinicalTrials.gov registry record · NA
Influenza Immunization in Adults Over Age 75
A NA study of Influenza and Older Adults, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,025
- Enrollment target
- 1
- Study location
NCT02200276 is a NA study of Influenza and Older Adults that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,025 participants, below the 36,797-participant average among 156 other Influenza trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02200276, a NA study of Influenza and Older Adults, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,025 participants
- Enrollment target
- 1
- Study location
Study Summary
The immune system is the part of the body that protects against infection. The immune system often doesn't work as effectively as people get older. This research is being done to find out how the immune systems in older people who are over age 75 respond to influenza vaccine (flu shot). We also want to find out if chronic cytomegalovirus (CMV) infection, a common virus infection in older persons affects the immune response in people older than 75 years of age who receive a flu shot. The Flu Shot is a vaccine approved for the prevention of influenza ("Flu") infections and is recommended every year for all persons 50 years and older. People who are older than 75 years of age are considered healthy or frail may join. A total of 1025 persons will be participating in this study. In order to determine if you are qualified for the study, we would ask you to answer a few questions over the phone that will take approximately 5 minutes. If you qualify and agree to proceed, you will be asked to come to Johns Hopkins Bayview Medical Center or, if you are unable to come to Bayview, one of our staff can visit you at your home. During that visit we obtain consent, review your medical history, and measure your vital signs, walking speed and grip strength. We will also administer a few brief questionnaires and collect urine and blood samples. We will then give you the Influenza vaccine for free. 7 days post receiving your Influenza Vaccine we will collect a small blood sample for further immune system testing. also, you will be asked to complete a 12-question survey which will assess your symptoms over the past 7 days (post receiving the Influenza vaccine). Also 4 weeks post receiving your Influenza vaccine you will be asked to complete a third visit that will include follow up health questionnaires and an influenza symptoms assessment questionnaire and vital signs. A third blood draw will be collected (approximately 10 teaspoons) to measure immune responses to the influenza vaccin
Conditions Studied
Interventions
- BIOLOGICAL Influenza
Study Locations (1)
Maryland
- Johns Hopkins University; JHAAC 5501 Hopkins Bayview Circle, 1B84 - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,025 participants |
| Start Date | 2014-03 |
| Est. Completion | 2027-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02200276
The ClinicalTrials.gov registry entry for NCT02200276 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,025 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,797-participant average among 156 other Influenza trials with a reported enrollment target (97% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which Influenza is the first listed.
NCT02200276 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02200276 about?
NCT02200276 is a clinical study titled "Influenza Immunization in Adults Over Age 75". The immune system is the part of the body that protects against infection. The immune system often doesn't work as effectively as people get older. This research is being done to find out how the immune systems in older people who are over age 75 respond to influenza vaccine (flu shot). We also want...
What is the current status of trial NCT02200276?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,025 participants. The study started on 2014-03. Estimated completion is 2027-11-30.
What conditions does trial NCT02200276 study?
This clinical trial studies the following conditions: Influenza, Older Adults, Immunization, Over Age 75.
What interventions are being tested in trial NCT02200276?
The interventions under investigation include: Influenza (BIOLOGICAL).
Who is sponsoring clinical trial NCT02200276?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02200276 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Immune Defense Protein Impact On Respiratory Immune Outcomes
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
RECRUITING · NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
ACTIVE NOT RECRUITING · NA
-
Exercise and COVID-19 Viral T-cell Immunity
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.